(Q83682066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

M A Hospital

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

X Thomas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S Castaigne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

E Raffoux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

C Pautas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

C Gardin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J-H Bourhis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

O Reman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

T de Revel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

C Terré

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

P Fenaux

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M Michallet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

G Socié

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

H Dombret

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

19 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1436-1441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426749%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2012.49

26 January 2020

exact match

0 references

cites work

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Analysis of time to death after transplantation when transplants are only given to patients in remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021

Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.49

7 January 2021